Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DIST_0902_scitranslmed.abb3774

Repeat expansion-targeting antisense oligo for ALS and frontotemporal dementia

Sep 29, 2020 | 1:03 AM GMT

DISEASE CATEGORY: Neurology

INDICATION: Amyotrophic lateral sclerosis (ALS); frontotemporal

Read the full 218 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE